4.525
price down icon4.74%   -0.225
after-market Handel nachbörslich: 4.53 0.005 +0.11%
loading

Coya Therapeutics Inc Aktie (COYA) Neueste Nachrichten

pulisher
Mar 10, 2026

Coya Therapeutics (COYA) to Release Quarterly Earnings on Tuesday - Defense World

Mar 10, 2026
pulisher
Mar 07, 2026

Is Coya Therapeutics Inc. impacted by rising ratesMarket Trend Report & Intraday High Probability Alerts - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Aug Reactions: Is Coya Therapeutics Inc impacted by rising ratesLayoff News & Technical Buy Zone Confirmations - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Stock Analysis: Is Coya Therapeutics Inc impacted by rising rates2025 Market WrapUp & AI Enhanced Trading Signals - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

Aug Mood: Is Coya Therapeutics Inc benefiting from innovation trendsEarnings Overview Report & AI Driven Stock Reports - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

COYA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Feb 28, 2026

New Highs: Is Coya Therapeutics Inc impacted by rising rates - baoquankhu1.vn

Feb 28, 2026
pulisher
Feb 28, 2026

Trading the Move, Not the Narrative: (COYA) Edition - Stock Traders Daily

Feb 28, 2026
pulisher
Feb 27, 2026

Coya Therapeutics, Inc. (NASDAQ:COYA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

Should I buy Coya Therapeutics Inc. stock nowGDP Growth & Real-Time Sentiment Analysis - mfd.ru

Feb 26, 2026
pulisher
Feb 25, 2026

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Feb 25, 2026
pulisher
Feb 20, 2026

What’s the RSI of Coya Therapeutics Inc. stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Feb 19, 2026
pulisher
Feb 19, 2026

Coya Therapeutics Details ALS Combo Immunotherapy Plan, Highlights Early Biomarker Signals in Webinar - Defense World

Feb 19, 2026
pulisher
Feb 18, 2026

Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from D. Boral Capital - MarketBeat

Feb 18, 2026
pulisher
Feb 18, 2026

Coya Therapeutics (COYA) Receives Buy Rating from Jason Kolbert - GuruFocus

Feb 18, 2026
pulisher
Feb 13, 2026

COYA Should I Buy - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Exosomes Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO - Barchart.com

Feb 13, 2026
pulisher
Feb 11, 2026

Published on: 2026-02-11 23:08:14 - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 10, 2026

Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial - BioSpace

Feb 10, 2026
pulisher
Feb 10, 2026

Houston biotech co. raises $11M to advance ALS drug development - InnovationMap

Feb 10, 2026
pulisher
Feb 06, 2026

New funding backs commercial readiness efforts for ALS therapy - ALS News Today

Feb 06, 2026
pulisher
Feb 06, 2026

Price-Driven Insight from (COYA) for Rule-Based Strategy - Stock Traders Daily

Feb 06, 2026
pulisher
Feb 05, 2026

HC Wainwright Predicts Higher Earnings for Coya Therapeutics - Defense World

Feb 05, 2026
pulisher
Feb 04, 2026

HC Wainwright Analysts Raise Earnings Estimates for COYA - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from HC Wainwright - Defense World

Feb 03, 2026
pulisher
Feb 02, 2026

Coya Therapeutics Announces $11.1 Million Private Placement - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

Coya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at HC Wainwright - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Take Profit: Is Coya Therapeutics Inc impacted by rising ratesWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

Aug Outlook: Is Coya Therapeutics Inc impacted by rising ratesQuarterly Performance Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 01, 2026

Aug Drivers: Will ACXP outperform its industry peersMarket Movement Recap & High Return Trade Guides - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Market Fear: Does Coya Therapeutics Inc have strong fundamentals2025 Top Decliners & Low Risk Entry Point Guides - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement - Yahoo Finance

Jan 31, 2026
pulisher
Jan 30, 2026

Coya Therapeutics secures $11.1 million in private placement By Investing.com - Investing.com Australia

Jan 30, 2026
pulisher
Jan 30, 2026

Coya Therapeutics secures $11.1 million in private placement - Investing.com India

Jan 30, 2026
pulisher
Jan 30, 2026

Coya Therapeutics Sets $11.1 Million Private Placement Led by Dr. Reddy’s And Greenlight Capital - Pulse 2.0

Jan 30, 2026
pulisher
Jan 30, 2026

Coya Therapeutics raises $11.1M in private placement led by Dr. Reddy's - MSN

Jan 30, 2026
pulisher
Jan 30, 2026

Dr. Reddy's (RDY) Invests in Coya Therapeutics' Private Placemen - GuruFocus

Jan 30, 2026
pulisher
Jan 30, 2026

Coya Therapeutics Announces Strategic Private Placement Financing - TipRanks

Jan 30, 2026
pulisher
Jan 30, 2026

Coya Therapeutics Signs Securities Purchase Agreement With Dr. Reddy's Labs - TradingView

Jan 30, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):